News

Emergency Department Study Demonstrates Utility of MediPines AGM100 in Triaging COVID-19 Patients

YORBA LINDA, Calif.--(BUSINESS WIRE)--#ERbestpractices--In a study presented at the American Thoracic Society (ATS) International Conference 2022, the MediPines AGM100 was…

2 years ago

Tivic Health Receives Second Global Health & Pharma Award: ClearUP Named 2022 Most Innovative Sinus Relief Solution

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today…

2 years ago

Beltone Introduces Custom Rechargeable Hearing Aids in a Modern Earbud Design

The innovative hearing aids are weatherproof, rechargeable, and custom made allowing for all day comfort, making them ideal for all…

2 years ago

Goodbody Health Granted Care Quality Commission Registration

VANCOUVER, BC / ACCESSWIRE / June 16, 2022 / Goodbody Health Inc. (CSE:GDBY)(OTCQB:GDBYF) ("Goodbody Health" or the "Company") is pleased…

2 years ago

Aerami Therapeutics Appoints Lisa Yañez as Chief Operating Officer

DURHAM, N.C., June 16, 2022 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (the “Company”), a biopharmaceutical company focused on developing inhaled…

2 years ago

Skylight Health Announces Appointment of Interim Chief Financial Officer and Corporate Update

TORONTO, June 16, 2022 (GLOBE NEWSWIRE) -- Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state…

2 years ago

INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT

HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the…

2 years ago

Lenire Biosciences Completes License Agreement with University College London for VSN16R, A Novel Clinical Candidate Treatment for Fragile X Syndrome

SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Lenire Biosciences Inc., a biopharmaceutical company developing novel treatments for Fragile X…

2 years ago

GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse

- Intelligent Fingerprinting Limited’s commercial-stage, revenue-generating platform technology would provide an expanded product upon which to leverage the existing GBS…

2 years ago

Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual Meeting

SEATTLE, June 16, 2022 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune…

2 years ago